USPTO serial 79041002
LEVETAM
Reviewed by CopyMark Law Group
Reg. 3409487Status 404
- Filing date
- Status date
- Registration date
- Apr 8, 2008
- Examiner
- BUNCH, TASHIA AUNGELIK
- Law office
- POST REGISTRATION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LEVETAM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations acting on the central nervous system | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by UCB PHARMA, Société Anonyme
- Other trademarks owned by UCB PHARMA, Société Anonyme
- Other trademarks owned by UCB PHARMA, Société Anonyme
- Other trademarks in Class 005
- Similar marks named LEVETAM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 5, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jan 5, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 11, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 26, 2015 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Aug 26, 2015 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jul 28, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 28, 2014 | C71T | CANCELLED SECTION 71 | — |
| Dec 22, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 1, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 1, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 8, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 8, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 22, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 2, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 20, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 20, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 28, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Nov 28, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 28, 2007 | ALIE | ASSIGNED TO LIE | — |
| Oct 25, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 19, 2007 | PAPER RECEIVED | — | |
| Oct 19, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 1, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 1, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 29, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 28, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 24, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Aug 23, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |